Arvinas, Inc.
ARVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001655759
No open-market purchases or sales by Arvinas, Inc. insiders were filed in the last 90 days; 201 institutions reported holding it in 13F filings for Q2 2026, worth $468.7M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Arvinas, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 207
- +2 vs. Q4 2025
- Shares held
- 54.2M
- +5.47M (+11.2%) vs. Q4 2025
- Total value
- $572.6M
- −$4.56M (−0.8%) vs. Q4 2025
- New holders
- 34
- 64 more added
- Sold out
- 32
- 70 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 201 | $468.7M |
| Q1 2026 | 207 | $572.6M |
| Q4 2025 | 206 | $662.9M |
| Q3 2025 | 211 | $570.7M |
| Q2 2025 | 215 | $513.8M |
| Q1 2025 | 216 | $456.7M |
| Q4 2024 | 199 | $1.47B |
| Q3 2024 | 206 | $1.78B |
| Q2 2024 | 207 | $1.89B |
| Q1 2024 | 223 | $2.84B |
| Q4 2023 | 213 | $2.67B |
| Q3 2023 | 155 | $959.0M |
| Q2 2023 | 156 | $1.16B |
| Q1 2023 | 171 | $1.34B |
| Q4 2022 | 162 | $1.71B |
| Q3 2022 | 174 | $2.22B |
| Q2 2022 | 172 | $2.08B |
| Q1 2022 | 179 | $3.16B |
| Q4 2021 | 199 | $3.69B |
| Q3 2021 | 205 | $3.64B |
| Q2 2021 | 181 | $3.52B |
| Q1 2021 | 181 | $2.88B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Arvinas, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,978,000 | $21.0M | 0.69% | +178,000+9.9% | Added |
| TCG Crossover Management, LLC | 2,387,461 | $25.3M | 0.72% | −278,755−10.5% | Reduced |
| Vanguard Capital Management LLC | 2,689,362 | $28.5M | 0.00% | +2,689,362 | New |
| Pfizer Inc | 3,457,815 | $34.9M | 14.63% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 3,638,567 | $38.6M | 0.03% | −50,634−1.4% | Reduced |
| Vanguard Portfolio Management LLC | 3,889,628 | $41.2M | 0.00% | +3,889,628 | New |
| BlackRock, Inc. | 6,797,584 | $72.1M | 0.00% | −524,917−7.2% | Reduced |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −619,900−100.0% | Sold out |
| Arbiter Partners Capital Management LLC | 0 | $0 | 0.00% | −452,789−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −261,756−100.0% | Sold out |
| Hussman Strategic Advisors, Inc. | 0 | $0 | 0.00% | −105,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −91,999−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −91,019−100.0% | Sold out |
| Monaco Asset Management SAM | 0 | $0 | 0.00% | −70,253−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −68,057−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −58,071−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −49,531−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −47,850−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −41,456−100.0% | Sold out |
| State of Tennessee, Treasury Department | 0 | $0 | 0.00% | −27,212−100.0% | Sold out |
| IMC-Chicago, LLC | 0 | $0 | 0.00% | −30,219−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −18,495−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −17,650−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −17,607−100.0% | Sold out |
| AlphaGrep UK Ltd | 0 | $0 | 0.00% | −16,999−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −13,206−100.0% | Sold out |
| Great Lakes Advisors, LLC | 0 | $0 | 0.00% | −11,621−100.0% | Sold out |
| Abel Hall, LLC | 0 | $0 | 0.00% | −10,534−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −10,438−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −3,332−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −2,061−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −1,617−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −700−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −629−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −252−100.0% | Sold out |
| Whittier Trust Co of Nevada Inc | 0 | $0 | 0.00% | −145−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −42,000−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |